Publications

Fins JJ, Wright MS, Giacino JT, Henderson J, Schiff ND.  2021.  In Pursuit of Agency Ex Machina: Expanding the Map in Severe Brain Injury.. AJOB Neurosci. 12(2-3):200-202.

Che A, García NVDe Marco.  2021.  An in vivo Calcium Imaging Approach for the Identification of Cell-Type Specific Patterns in the Developing Cortex.. Front Neural Circuits. 15:747724.

Navi BB, Sherman CP, Genova R, Mathias R, Lansdale KN, LeMoss NM, Wolfe J, Skakodub A, Kamel H, Tagawa ST et al..  2021.  Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study.. Ann Neurol. 90(1):159-169.

Gureev AP, Sadovnikova IS, Shaforostova EA, Starkov AA, Popov VN.  2021.  Mildronate protects heart mtDNA from oxidative stress toxicity induced by exhaustive physical exercise.. Arch Biochem Biophys. 705:108892.

Notaras M, Lodhi A, Barrio-Alonso E, Foord C, Rodrick T, Jones D, Fang H, Greening D, Colak D.  2021.  Neurodevelopmental signatures of narcotic and neuropsychiatric risk factors in 3D human-derived forebrain organoids.. Mol Psychiatry.

Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.

Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.

Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.

Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.

Notaras M, Lodhi A, Fang H, Greening D, Colak D.  2021.  The proteomic architecture of schizophrenia iPSC-derived cerebral organoids reveals alterations in GWAS and neuronal development factors.. Transl Psychiatry. 11(1):541.

Garcia-Bonilla L, Sciortino R, Shahanoor Z, Racchumi G, Janakiraman M, Montaner J, Zhou P, Anrather J, Iadecola C.  2021.  Role of microglial and endothelial CD36 in post-ischemic inflammasome activation and interleukin-1β-induced endothelial activation.. Brain Behav Immun.

Lopez-Lee C, Kodama L, Gan L.  2021.  Sex Differences in Neurodegeneration: The Role of the Immune System in Humans.. Biol Psychiatry.

Yang J, Ma Q, Dincheva I, Giza J, Jing D, Marinic T, Milner TA, Rajadhyaksha A, Lee FS, Hempstead BL.  2021.  SorCS is highly expressed in the CA2 region of the hippocampus and is enriched in the postsynaptic region.. Mol Psychiatry. 26(3):721.

Vabres P, Sorlin A, Kholmanskikh SS, Demeer B, St-Onge J, Duffourd Y, Kuentz P, Courcet J-B, Carmignac V, Garret P et al..  2020.  Author Correction: Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome.. Nat Genet.

Vabres P, Sorlin A, Kholmanskikh SS, Demeer B, St-Onge J, Duffourd Y, Kuentz P, Courcet J-B, Carmignac V, Garret P et al..  2020.  Author Correction: Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome.. Nat Genet.

Vabres P, Sorlin A, Kholmanskikh SS, Demeer B, St-Onge J, Duffourd Y, Kuentz P, Courcet J-B, Carmignac V, Garret P et al..  2020.  Author Correction: Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome.. Nat Genet.

Vabres P, Sorlin A, Kholmanskikh SS, Demeer B, St-Onge J, Duffourd Y, Kuentz P, Courcet J-B, Carmignac V, Garret P et al..  2020.  Author Correction: Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome.. Nat Genet.

P Ozdinler H, Gautam M, Gozutok O, Konrad C, Manfredi G, Gomez EArea, Mitsumoto H, Erb ML, Tian Z, Haase G.  2020.  Better understanding the neurobiology of primary lateral sclerosis.. Amyotroph Lateral Scler Frontotemporal Degener. 21(sup1):35-46.

P Ozdinler H, Gautam M, Gozutok O, Konrad C, Manfredi G, Gomez EArea, Mitsumoto H, Erb ML, Tian Z, Haase G.  2020.  Better understanding the neurobiology of primary lateral sclerosis.. Amyotroph Lateral Scler Frontotemporal Degener. 21(sup1):35-46.

P Ozdinler H, Gautam M, Gozutok O, Konrad C, Manfredi G, Gomez EArea, Mitsumoto H, Erb ML, Tian Z, Haase G.  2020.  Better understanding the neurobiology of primary lateral sclerosis.. Amyotroph Lateral Scler Frontotemporal Degener. 21(sup1):35-46.

Telesford KM, Kaunzner UW, Perumal J, Gauthier SA, Wu X, Díaz I, Kruse-Hoyer M, Engel C, Marcille M, Vartanian T.  2020.  Black African and Latino/a identity correlates with increased plasmablasts in MS.. Neurol Neuroimmunol Neuroinflamm. 7(1)

Cristóvão AClara, Campos FL, Je G, Esteves M, Guhathakurta S, Yang L, M Beal F, Fonseca BM, Salgado AJ, Queiroz J et al..  2020.  Characterization of a Parkinson's disease rat model using an upgraded paraquat exposure paradigm.. Eur J Neurosci.

Comanducci A, Boly M, Claassen J, De Lucia M, Gibson RM, Juan E, Laureys S, Naccache L, Owen AM, Rosanova M et al..  2020.  Clinical and advanced neurophysiology in the prognostic and diagnostic evaluation of disorders of consciousness: review of an IFCN-endorsed expert group.. Clin Neurophysiol. 131(11):2736-2765.

Gureev AP, Popov VN, Starkov AA.  2020.  Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation.. Exp Neurol. 328:113285.

J Provencio J, J Hemphill C, Claassen J, Edlow BL, Helbok R, Vespa PM, Diringer MN, Polizzotto L, Shutter L, Suarez JI et al..  2020.  The Curing Coma Campaign: Framing Initial Scientific Challenges-Proceedings of the First Curing Coma Campaign Scientific Advisory Council Meeting.. Neurocrit Care.